" /> Gandotinib - CISMeF





Preferred Label : Gandotinib;

NCIt synonyms : 3-(4-Chloro-2-fluorobenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(Morpholinomethyl)imidazo(1,2-b)pyridazin-6-amine;

NCIt definition : An orally bioavailable imidazopyridazine and inhibitor of Janus kinase 2 mutant V617F (JAK2V617F), with potential antineoplastic activity. Upon oral administration, gandotinib selectively and competitively inhibits the activation of JAK2V617F, which may result in the inhibition of the JAK-STAT signaling pathway and the induction of apoptosis in JAK2V617F-expressing tumor cells. JAK2V617F has a substitution of phenylalanine for valine at amino acid position 617 and plays a key role in tumor cell proliferation and survival.;

UNII : ANC71R916O;

InChIKey : SQSZANZGUXWJEA-UHFFFAOYSA-N;

CAS number : 1229236-86-5; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1229236-86-5 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : LY2784544; LY 2784544;

Details


You can consult :


Nous contacter.
08/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.